Handelsbanken Fonder AB - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$133,000
-28.1%
37,0000.0%0.00%0.0%
Q4 2021$185,000
-30.2%
37,0000.0%0.00%0.0%
Q3 2021$265,000
-22.7%
37,0000.0%0.00%
-50.0%
Q2 2021$343,000
+13.6%
37,000
+13.8%
0.00%0.0%
Q1 2021$302,000
+4.9%
32,5000.0%0.00%0.0%
Q4 2020$288,00032,5000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders